Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2000-8-22
pubmed:abstractText
To compare the antiviral activity of abacavir (ABC) with stable background therapy (SBG) and SBG alone in antiretroviral therapy-experienced subjects as demonstrated by the proportion of subjects with plasma HIV-1 RNA < or = 400 copies/ml, plasma HIV-1 RNA and CD4 cell count profiles, and safety and tolerance of the two regimens over 16 weeks.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0269-9370
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
781-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10839585-Adolescent, pubmed-meshheading:10839585-Adult, pubmed-meshheading:10839585-Anti-HIV Agents, pubmed-meshheading:10839585-CD4 Lymphocyte Count, pubmed-meshheading:10839585-Dideoxynucleosides, pubmed-meshheading:10839585-Double-Blind Method, pubmed-meshheading:10839585-Drug Resistance, Microbial, pubmed-meshheading:10839585-Drug Therapy, Combination, pubmed-meshheading:10839585-Female, pubmed-meshheading:10839585-Genotype, pubmed-meshheading:10839585-HIV Infections, pubmed-meshheading:10839585-HIV Reverse Transcriptase, pubmed-meshheading:10839585-HIV-1, pubmed-meshheading:10839585-Humans, pubmed-meshheading:10839585-Male, pubmed-meshheading:10839585-Middle Aged, pubmed-meshheading:10839585-Phenotype, pubmed-meshheading:10839585-RNA, Viral, pubmed-meshheading:10839585-Reverse Transcriptase Inhibitors, pubmed-meshheading:10839585-Treatment Outcome, pubmed-meshheading:10839585-Viral Load
pubmed:year
2000
pubmed:articleTitle
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study Team.
pubmed:affiliation
Hopital de la Pitie Salpetriere, Paris, France.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III